Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5080771 | 0.80 | PDE3B (0.39) | — | |
| SCHEMBL5078981 | 0.73 | NPSR1 (0.38) | — | |
| SCHEMBL4601709 | 0.72 | NTRK1 (0.38) | — | |
| SCHEMBL1591434 | 0.72 | NTRK1 (0.33) | — | |
| SCHEMBL9208485 | 0.72 | RPS6KB1 (0.36) | — | |
| SCHEMBL3094967 | 0.72 | RET (0.37) | IRAK4 | |
| SCHEMBL23566780 | 0.71 | CXCR4 (0.40) | — | |
| Hydrochloric Acid SCHEMBL28042958 | 0.71 | GRIN3B (0.32) | — | |
| SCHEMBL22583344 | 0.69 | PARP1 (0.46) | — | |
| SCHEMBL31678664 | 0.69 | PARP1 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080132505-A1 | Combination Of Cb2 Modulators And Pde4 Inhibitors For Use In Medicine | GLAXO GROUP LIMITED | 2008-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080132505-A1 | Combination Of Cb2 Modulators And Pde4 Inhibitors For Use In Medicine | CNR2, CNR1, PDE4A | LNPEP 2968/4885IRAK4 448/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.